BRCA1 and peritoneum cancer: In carriers of a pathogenic BRCA1 mutation, the prevalence of ovarian, fallopian tube, and peritoneal cancers found during RRSO was 1.5% for those under 40 years old and 3.8% for those between 40 and 49 years old.